Andreas–Antonios Roussakis

767 total citations
27 papers, 565 citations indexed

About

Andreas–Antonios Roussakis is a scholar working on Neurology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Andreas–Antonios Roussakis has authored 27 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Andreas–Antonios Roussakis's work include Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (17 papers) and Advanced Neuroimaging Techniques and Applications (4 papers). Andreas–Antonios Roussakis is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (17 papers) and Advanced Neuroimaging Techniques and Applications (4 papers). Andreas–Antonios Roussakis collaborates with scholars based in United Kingdom, United States and Spain. Andreas–Antonios Roussakis's co-authors include Paola Piccini, Nicholas P Lao–Kaim, Marios Politis, Antonio Martín‐Bastida, Roger A. Barker, David Towey, Thomas Foltynie, Håkan Widner, Michal Rolinski and Konrad Szewczyk‐Królikowski and has published in prestigious journals such as Brain, Neurology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Andreas–Antonios Roussakis

26 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas–Antonios Roussakis United Kingdom 14 374 161 109 96 74 27 565
Pantelis Stathis Greece 14 288 0.8× 152 0.9× 31 0.3× 118 1.2× 104 1.4× 36 565
Thomas Schwarzlmüller Norway 9 145 0.4× 92 0.6× 92 0.8× 99 1.0× 168 2.3× 15 547
David Gosal United Kingdom 13 344 0.9× 179 1.1× 53 0.5× 60 0.6× 113 1.5× 28 690
Dulce Neutel Portugal 8 313 0.8× 137 0.9× 50 0.5× 70 0.7× 82 1.1× 15 415
Yafell Serulle United States 15 325 0.9× 313 1.9× 68 0.6× 31 0.3× 164 2.2× 43 708
Marek Harat Poland 13 200 0.5× 75 0.5× 50 0.5× 29 0.3× 90 1.2× 70 552
Emma Biondetti Italy 13 340 0.9× 122 0.8× 218 2.0× 63 0.7× 84 1.1× 25 591
Andres Deik United States 16 379 1.0× 188 1.2× 35 0.3× 51 0.5× 140 1.9× 33 722
Isabelle Quelven France 10 248 0.7× 261 1.6× 83 0.8× 51 0.5× 193 2.6× 15 652

Countries citing papers authored by Andreas–Antonios Roussakis

Since Specialization
Citations

This map shows the geographic impact of Andreas–Antonios Roussakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas–Antonios Roussakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas–Antonios Roussakis more than expected).

Fields of papers citing papers by Andreas–Antonios Roussakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas–Antonios Roussakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas–Antonios Roussakis. The network helps show where Andreas–Antonios Roussakis may publish in the future.

Co-authorship network of co-authors of Andreas–Antonios Roussakis

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas–Antonios Roussakis. A scholar is included among the top collaborators of Andreas–Antonios Roussakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas–Antonios Roussakis. Andreas–Antonios Roussakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rothman, Alexander, Sofía S. Villar, Jennifer Middleton, et al.. (2025). Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study. American Journal of Respiratory and Critical Care Medicine. 211(6). 1018–1027. 6 indexed citations
2.
Xing, Yue, Antonio Martín‐Bastida, Andreas–Antonios Roussakis, et al.. (2025). Diagnostic Value of Swallow Tail Sign at Brain MRI in Patients with Clinically Uncertain Parkinsonian Syndrome. Radiology. 316(1). e240680–e240680.
3.
Rothman, Alexander, Sofía S. Villar, Martin Law, et al.. (2024). Positioning Imatinib for Pulmonary Arterial Hypertension (PIPAH) study. European Heart Journal. 45(Supplement_1). 2 indexed citations
4.
Roussakis, Andreas–Antonios, Mark Forrest Gordon, Ralf Reilmann, et al.. (2023). A PET-CT study on neuroinflammation in Huntington’s disease patients participating in a randomized trial with laquinimod. Brain Communications. 5(2). fcad084–fcad084. 13 indexed citations
5.
Wilkins, Martin R., Mikel A. McKie, Martin Law, et al.. (2021). Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single‐arm efficacy. Pulmonary Circulation. 11(4). 1–12. 18 indexed citations
6.
Lao–Kaim, Nicholas P, Antonio Martín‐Bastida, Andreas–Antonios Roussakis, et al.. (2021). Longitudinal changes in movement-related functional MRI activity in Parkinson's disease patients. Parkinsonism & Related Disorders. 87. 61–69. 6 indexed citations
7.
Jenkins, Peter O, Andreas–Antonios Roussakis, Sara De Simoni, et al.. (2020). Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson’s disease. Journal of Neurology Neurosurgery & Psychiatry. 91(6). 631–637. 14 indexed citations
8.
Roussakis, Andreas–Antonios, et al.. (2020). Multimodal dopamine transporter (DAT) imaging and magnetic resonance imaging (MRI) to characterise early Parkinson's disease. Parkinsonism & Related Disorders. 79. 26–33. 13 indexed citations
9.
Zeng, Zhou, Andreas–Antonios Roussakis, Nicholas P Lao–Kaim, & Paola Piccini. (2020). Astrocytes in Parkinson's disease: from preclinical assays to in vivo imaging and therapeutic probes. Neurobiology of Aging. 95. 264–270. 11 indexed citations
10.
Li, Weihua, Nicholas P Lao–Kaim, Andreas–Antonios Roussakis, et al.. (2020). Longitudinal functional connectivity changes related to dopaminergic decline in Parkinson’s disease. NeuroImage Clinical. 28. 102409–102409. 28 indexed citations
11.
Roussakis, Andreas–Antonios, et al.. (2019). Dopamine Transporter Density in de novo Parkinson's Disease Does Not Relate to the Development of Levodopa-Induced Dyskinesias.. PubMed. 3(1). 10000–10000. 6 indexed citations
12.
Roussakis, Andreas–Antonios, Nicholas P Lao–Kaim, & Paola Piccini. (2019). Brain Imaging and Impulse Control Disorders in Parkinson’s Disease. Current Neurology and Neuroscience Reports. 19(9). 67–67. 12 indexed citations
13.
Roussakis, Andreas–Antonios, et al.. (2019). Parkinson’s Disease Dyskinesias Possibly Relate to Greater Dopamine Transporter Losses in the Putamen Over Time. Spiral (Imperial College London). 5(S1). 2 indexed citations
14.
Martín‐Bastida, Antonio, Nicholas P Lao–Kaim, Andreas–Antonios Roussakis, et al.. (2019). Relationship between neuromelanin and dopamine terminals within the Parkinson’s nigrostriatal system. Brain. 142(7). 2023–2036. 52 indexed citations
15.
Roussakis, Andreas–Antonios & Paola Piccini. (2018). Molecular Imaging of Neuroinflammation in Idiopathic Parkinson's Disease. International review of neurobiology. 141. 347–363. 15 indexed citations
16.
Rolinski, Michal, Ludovica Griffanti, Paola Piccini, et al.. (2016). Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson’s disease. Brain. 139(8). 2224–2234. 108 indexed citations
17.
Roussakis, Andreas–Antonios, Marios Politis, David Towey, & Paola Piccini. (2016). Serotonin-to-dopamine transporter ratios in Parkinson disease. Neurology. 86(12). 1152–1158. 67 indexed citations
18.
Roussakis, Andreas–Antonios, Marios Politis, David Towey, & Paola Piccini. (2015). Parkinson’s disease progression is associated with increased putaminal serotonin to dopamine transporter ratio: relevance for dyskinesias (I3-1B). Neurology. 84(14_supplement). 1 indexed citations
19.
Roussakis, Andreas–Antonios & Paola Piccini. (2015). PET Imaging in Huntington’s Disease. Journal of Huntington s Disease. 4(4). 287–296. 13 indexed citations
20.
Papanikolaou, Nickolas, et al.. (2002). Biexponential T2 Relaxation Time Analysis of the Brain. Investigative Radiology. 37(7). 363–367. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pantelis Stathis Breakdown of academic impact, for papers by Thomas Schwarzlmüller Breakdown of academic impact, for papers by David Gosal Breakdown of academic impact, for papers by Dulce Neutel Breakdown of academic impact, for papers by Yafell Serulle Breakdown of academic impact, for papers by Marek Harat Breakdown of academic impact, for papers by Emma Biondetti Breakdown of academic impact, for papers by Andres Deik Breakdown of academic impact, for papers by Isabelle Quelven
Rankless by CCL
2026